These observations are consistent with published studies, which have shown a marked decrease of ApoA1 levels in AD plasma and serum [21],[55] and demonstrated that decreased serum ApoA1 concentrations were highly correlated with the severity of AD [56]. Here, APOA1 is linked to Alzheimer disease.